TRACON Pharmaceuticals Announces Top-line Data from Phase 2 TRAXAR Clinical Trial in Renal Cell Carcinoma
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
RZOLV Technologies Appoints Mary Ellen Thorburn to the Board of Directors; Announces the Retirement of Darryl Yea
Homerun Resources Inc. Announces Positive Results of Confirmation Testing by Minerali Industriali Engineering on the Santa Maria Eterna Silica Sand for the Manufacture of Antimony-Free Solar Glass
HyProMag USA Finalizes Long Term Lease for Dallas-Fort Worth Rare Earth Magnet Recycling and Manufacturing Hub
